Argus Upgrades Eli Lilly (LLY) to Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/15/2026
- S&P 500, Nasdaq set for lower open as AI stocks slide on debt concerns
- U.S. producer prices rise by 1.3% month-on-month in September
- Brent oil slips as US weighs easing sanctions on Russia's 'shadow fleet'
- UBS now expects a third Fed rate hike after hot September inflation print
- Tesla-SpaceX Merger could be announced before December, Barclays says
Tweet
Share
E-mailGet Alerts LLY Hot Sheet
Price: $1,244.80 +2.98%
Rating Summary:
31 Buy, 4 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 15 | Down: 9 | New: 31
Rating Summary:
31 Buy, 4 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 15 | Down: 9 | New: 31
Join SI Premium – FREE
Argus upgraded Eli Lilly (NYSE: LLY) from Hold to Buy.
For more ratings news on Eli Lilly click here and for the rating history of Eli Lilly click here.
Shares of Eli Lilly closed at $35.64 yesterday.
For more ratings news on Eli Lilly click here and for the rating history of Eli Lilly click here.
Shares of Eli Lilly closed at $35.64 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lilly's Omvoh shows composite disease control in bowel disease trials
- Morgan Stanley Upgrades Quantinuum Inc (QNT) to Overweight
- Deutsche Bank Upgrades Telia Co AB (TELIA:SS) (TLSNF) to Buy
Create E-mail Alert Related Categories
UpgradesRelated Entities
ArgusSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
